Profound Medical Corp. (PROF): EPS (Diluted)
$1.41
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.41 | +25.9% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $1.12 | -16.4% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $1.34 | n/a | 2025-03-07, From 2023-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Profound Medical Corp. (PROF) | 2025-12-31 | $1.41 | +25.9% |
| Biotricity Inc. (BTCY) | 2026-03-31 | -$0.12 | n/m |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$3.81 | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$2.07 | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $0.11 | +1000.0% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$1.89 | n/m |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$0.29 | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $10.12 | -17.5% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | -$0.98 | n/m |
Compare PROF, BTCY, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗